Revelation in ongoing $10–12m Series A raise for January close to support Covid-19 therapy and diagnostic development

Corona-Revelation
The company will most likely collaborate with an academic center treating a high volume of Covid-19 cases to conduct the study. Credit: Gerd Altmann from Pixabay